HP eNews Update - August 2017

www.menopause.org.au August 2018
HP eNews

Welcome to AMS HP eNews for doctors and other healthcare professionals who have a special interest in women's health. The content covers information and resources relevant to menopause, midlife and the promotion of healthy ageing.

In this edition


August 2017

Eating more vegetable protein may protect against early menopause

vegetablesIn this US study results suggested that long-term, high intake of vegetable protein from such foods as whole grains, soy and tofu, may protect women from early menopause and could prolong reproductive function. Consuming enriched pasta, dark bread and cold cereal were especially associated with lower risk, while the researchers observed no similar relation to eating animal sources of protein.

Participants were asked to report how often they ate a single serving of 131 foods, beverages and supplements over the previous year, from "never or less than once a month" to "more than six per day." The study observed that women consuming approximately 6.5 percent of their daily calories as vegetable protein had a significant 16 percent lower risk of early menopause compared to women whose intake was approximately 4 percent of calories...




Why some women are more likely to feel depressed

thoughtful womanThe primary goal of the study was to understand why some women are more vulnerable to depression, even though all women experience hormone fluctuations. The study included more than 1,300 regularly menstruating premenopausal women aged 42 to 52 years at study entry. 

A key finding was that longer duration of estrogen exposure from the start of menstruation until the onset of menopause was significantly associated with a reduced risk of depression during the transition to menopause and for up to 10 years postmenopause. Also noteworthy was that longer duration of birth control use was associated with a decreased risk of depression, but the number of pregnancies or incidence of breastfeeding had no association...




Early menopause is independently linked to an increased risk of developing type 2 diabetes

Previous research has shown that women with early onset of menopause (age below 45 years) have an increased risk of cardiovascular disease (CVD) and overall mortality, whereas an onset of menopause at age 50-54 years is linked to a reduced risk of CVD and mortality. While the increased risk is thought to be due to the adverse effects of menopause on CVD risk factors, the influence of age at menopause on these risk factors remains uncertain. 

The authors concluded that early onset of natural menopause is an independent marker for type 2 diabetes in postmenopausal women.




Knowledge and attitudes of health professionals regarding menopausal hormone therapies

In this Australian study the researchers evaluated the knowledge and attitudes of Australian health professionals (HPs) including general practitioners (GPs), gynecologists and endocrinologists, to menopausal hormone therapy (MHT).

Although most HPs will recommend MHT, when indicated, for symptomatic menopausal women, variations exist between specialties in prescribing practices. HPs’ knowledge gaps and perceived consumer concerns are barriers to prescribing MHT.




21st AMS Congress 2017

AMS Congress 2017 

The members of your local organising committee are delighted to invite you to attend the 21st Congress of the Australasian Menopause Society.

This year's congress will be held at the Sofitel Sydney Wentworth from Friday 13th to Sunday 15th of October. It promises to be a ripper!


Registration for AMS 2017 is now open. For more information, please visit the conference website www.ams2017.org/registration.


The preliminary program is available online, please click here www.ams2017.org/program-2/scientific-program/ to view.

21st Anniversary Dinner

Join us for an unforgettable night of great entertainment with Dr V’s Swing Thing 22-piece Big Band (click here to see the band) and a talk on “The Disappearing Woman” by social researcher and bestselling author Hugh Mackay.

Date: Saturday 14th October 6:30pm - 10:30pm
Cost: $149.00 and can be booked through your online profile during registration.  

We look forward to seeing you at the Congress in October.

Kind regards,

Sheila O’Neill
For the 2017 Organising Committee




RANZCOG ASM Menopause Workshop

Join AMS for Member's only content

See past AMS Congress videos, exclusive commentary on cases and studies such as:

2016 AMS Congress Presentations

Presentations from the 2016 AMS Congress held in Perth are now available for viewing (AMS members only access).   

Bones: The latest in osteoporosis management

See Dr Michael McClung, Founding Director of the Oregon Osteoporosis Centre, who is an internationally recognized expert in the fields of osteoporosis and bone density testing discuss the latest in osteoporosis management.

NAMS Menopause e-Consult

Question: A 27-year-old woman presents with severe hot flashes and night sweats secondary to primary ovarian insufficiency (POI) and from early menopause after chemotherapy for treatment of Hodgkin lymphoma. What is the best treatment approach?
Commentary by Monica M. Christmas, MD, FACOG, NCMP

Case: A 52-year-old premenopausal woman presents for her annual physical. Two weeks ago she had her annual mammogram, which was reported as negative for breast cancer but mentioned “extremely dense” breasts. She has heard that increased breast density increases her risk of breast cancer. She would like to understand the effect of breast density on her individual risk of breast cancer and learn what steps she can take to lower her individual risk. How do you counsel her?  
Commentary by Lauren F Cornell, MD; Dawn Mussallem, DO; and Sandhya Pruthi, MD

From Our Menopause World August 2017   

Løkkegaard E, Nielsen LH, Keiding N. Risk of stroke with various types of menopausal hormone therapies: a national cohort study. Stroke 2017;48:2266-9

Double-blind randomized studies on the effects of oral postmenopausal hormone therapies were stopped mainly because of increased risk of stroke. We aimed to assess the risk of all strokes and various subtypes associated with hormone therapy and explore the influence of regimens and routes of administration. 

From IMS Live

Longevity in women and reproductive factors?

In this ageing world, the field of the 'epidemiology of longevity' has been expanding rapidly in recent years. With a dramatic increase in survival rate to advanced old age over the past century, longevity can be described as an epidemic. Many studies have evaluated the impact of factors such as low socioeconomics in childhood, genetics, environmental, dietary and lifestyle (smoking and alcohol use), which negatively affect longevity. Although mortality rates for females are lower at each age than those of men, a close association between reproductive characteristics and longevity was recently documented.

Pharmacogenomics in personalized medicine: menopause perspectives

Pharmacogenomics is the study of how genes affect a person's response to drugs. This relatively new field combines pharmacology and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person's genetic make-up [1]. Many drugs that are currently available are 'one size fits all', but they don't work the same way for everyone. It can be difficult to predict who will benefit from a medication, who will not respond at all, and who will experience negative side-effects. Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patient's genotype, and to ensure maximum efficacy with minimal adverse effects.


Since its launch in 2008, the web-based fracture risk assessment tool FRAX® [1] has been evaluated thoroughly in additional validation studies and widely published in meta-analyses and clinical review papers. Furthermore, its predictive and discriminative powers have been compared with other osteoporotic fracture risk prediction tools [2]. 

Upcoming Conferences

Conferences 2017 upcoming

RANZCOG 2017 Annual Scientic Meeting
Auckland, New Zealand 
29 October - 1 November 2017 

25th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI)
Vienna, Austria
November 30 - December 2, 2017

16th World Congress on Menopause
Midlife Health in the 21st Century
6 - 9 June 2018
Vancover, Canada


AMS Congress 2017
Copyright © 2017
Australasian Menopause Society Ltd.
PO Box 280, Healesville VIC 3777
Tel: +61 3 9428 8738 | Email: ams@menopause.org.au
Join the AMS now
Contact us |